Drug interactions
Fingolimod + Tisagenlecleucel
Severity: Major
Fingolimod and Tisagenlecleucel: major interaction.
Last updated Sources: US FDA label
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Fingolimod lowers circulating lymphocytes, which may impair T-cell collection and CAR T expansion and persistence. It also adds to infection risk in patients who are already immunocompromised.
What this interaction means in plain words
Fingolimod and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Fingolimod belongs to Central Nervous System; Tisagenlecleucel belongs to Oncology.
Why it happens
Fingolimod sequesters lymphocytes via S1P receptor modulation, which may reduce T-cell function and number and adds to immunosuppression.
What to do
Avoid fingolimod around leukapheresis and CAR T infusion where possible and use an alternative. If it must continue, monitor lymphocyte counts and infection closely.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Tisagenlecleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
References
Other interactions of Fingolimod
- Adenovirus types 4 and 7 live + Fingolimod Contraindicated
- Bcg vaccine live + Fingolimod Contraindicated
- Fingolimod + Pimozide Contraindicated
- Fingolimod + Ponesimod Contraindicated
- Fingolimod + Quinidine Contraindicated
- Fingolimod + Siponimod Contraindicated
Other interactions of Tisagenlecleucel
Frequently asked questions
Can I take Fingolimod with Tisagenlecleucel?
MediHelp rates the interaction as major. Fingolimod and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Fingolimod lowers circulating lymphocytes, which may impair T-cell collection and CAR T expansion and persistence. It also adds to infection risk in patients who are already immunocompromised.
How serious is the interaction between Fingolimod and Tisagenlecleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid fingolimod around leukapheresis and CAR T infusion where possible and use an alternative. If it must continue, monitor lymphocyte counts and infection closely.
What other medicines interact with Fingolimod?
MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
